To investigate whether TIAM1 regulates sensitivity towards chemotherapeutic agents used in CRC patients, we conducted cytotoxicity assays with 5-FU, L-OHP, and CPT-11 in CRC cell lines with or without TIAM1 siRNA. This evidence concerns the gene TIAM1 and colorectal carcinoma.